Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-26

FDA Approved: RAMELTEON — Original Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Ramelteon as an original-application generic (ANDA 091693) for the treatment of insomnia characterized by difficulty with sleep onset.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

ORIG AP for RAMELTEON (RAMELTEON)